Neurocrine Biosciences Inc (NBIX)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 341,300 | 249,700 | 154,500 | 89,600 | 407,300 |
| Total assets | US$ in thousands | 3,718,700 | 3,251,400 | 2,368,700 | 2,072,500 | 1,734,700 |
| ROA | 9.18% | 7.68% | 6.52% | 4.32% | 23.48% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $341,300K ÷ $3,718,700K
= 9.18%
Neurocrine Biosciences Inc's Return on Assets (ROA) has experienced fluctuations over the past five years. Starting at a high of 23.48% on December 31, 2020, the ROA decreased significantly to 4.32% by December 31, 2021. However, there has been a gradual increase in ROA since then, reaching 9.18% as of December 31, 2024.
The declining ROA from 2020 to 2021 may indicate a period of lower profitability relative to the assets employed. The subsequent upward trend in ROA suggests that the company has been able to improve its efficiency in generating profits from its assets.
It is important to continue monitoring Neurocrine Biosciences Inc's ROA to assess the company's ability to generate returns from its assets effectively and sustainably over time.
Peer comparison
Dec 31, 2024